A New Option for Cluster Headache: gammaCore, Part II

GammaCore is a new device for acute, episodic cluster headaches and for prevention. It’s the first transcutaneous stimulator that targets the vagus nerve in the neck, and it’s FDA cleared.  Mark Mitchell will share the impressive effects of vagus nerve stimulation on his headaches, level of function, and emotional well-being. Then, Dr. Stephen Silberstein, Professor …

A New Option for Cluster Headache: gammaCore, Part I

GammaCore is a new device for acute, episodic cluster headaches and for prevention. It’s the first transcutaneous stimulator that targets the vagus nerve in the neck, and it’s FDA cleared.  Mark Mitchell will share the impressive effects of vagus nerve stimulation on his headaches, level of function, and emotional well-being. Then, Dr. Stephen Silberstein, Professor …

Benzodiazepine

Benzodiazepine Withdrawal Syndrome, Part II

It’s been called the benzodiazepine injury syndrome. Patients who stop using benzodiazepines may not go through a simple, acute withdrawal process. Instead, 10-15% of patients may experience a new, unexplained illness, leading to severe and disabling symptoms. Carrie Silvernail, our first guest shares her five and a half year battle with this protracted withdrawal syndrome. …

Benzodiazepine

Benzodiazepine Withdrawal Syndrome, Part I

It’s been called the benzodiazepine injury syndrome. Patients who stop using benzodiazepines may not go through a simple, acute withdrawal process. Instead, 10-15% of patients may experience a new, unexplained illness, leading to severe and disabling symptoms. Carrie Silvernail, our first guest shares her five and a half year battle with this protracted withdrawal syndrome. …

Expert Perspective: The Opioid Crisis and COVID-19

The ongoing 2019 coronavirus disease (COVID-19) pandemic has disrupted care provision for patients with pain disorders, as well as those with opioid use disorder. As a result, public health experts have voiced concern that the COVID-19 pandemic may worsen the opioid crisis in the United States, and the populations affected most seriously by both crises …

COVID-19 and NSAIDS: A Narrative Review of Knowns and Unknowns

Abstract Concern about the appropriate role of nonsteroidal anti-inflammatory drugs (NSAIDs) in COVID-19 speculate that NSAIDs, in particular ibuprofen, may upregulate the entry point for the virus, the angiotensin-converting enzyme (ACE) 2 receptors and increase susceptibility to the virus or worsen symptoms in existing disease. Adverse outcomes with COVID-19 have been linked to cytokine storm but …

6th Annual Pain Care for Primary Care

6th Annual Pain Care for Primary Care featuring Guest Speaker Dr. Christo

This Opioids vs Medical Cannabis Debate speakers were introduced by PCPC’s addiction expert, Ed Salsitz: “Up until now PCPC has been cordial and collegial, but now the gloves have come off for The Great Debate! I introduce to you: Johns Hopkins Jabber, Paul Christo, the East Coast Champion vs San Diego Slugger Dave Bazzo, the …

Getting Back on Your Feet: Ways to Treat and Prevent Osteoporosis

Getting Back on Your Feet: Ways to Treat and Prevent Osteoporosis

Osteoporosis literally means a porous bone, so if you develop this condition you have fragile and unhealthy bone. You also may hear experiences of patients (or by you if you have osteoporosis) describe this bone condition as painful with cracking bones. When an individual is dealing with osteoporosis, the bones become porous and fragile, and …

Thousands of suits brought against U.S. Drugmakers

Thousands of Suits Brought Against U.S. Drugmakers

Dr. Christo was a special guest on the news show Crossroads discussing the legal suits that have been brought against U.S. Drugmakers. Among the suits is one filed against Johnson & Johnson that claims they facilitated the opioid crisis. Watch the interview now! buy diflucan online https://bethanyhealthcare.org/wp-content/languages/new/diflucan.html generic medication buy benzac online https://bethanyhealthcare.org/wp-content/languages/new/benzac.html generic medication

First New Depression Drug Since Prozac

Dr. Christo is LIVE in the studio with Michelle Makoi from Clear Cut on I24. They discuss the FDA’s approval of a new class of drug for depression called Esketamine. This is an important breakthrough in the treatment of treatment-resistant depression. kamagra no prescription Buy Nolvadex online buy Strattera online